Medacta Group SA (MEDGF)
83.91
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Medacta Group Debt to Equity Ratio: 0.4885 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.4885 |
| June 30, 2023 | 0.00 |
| December 31, 2022 | 0.5189 |
| June 30, 2022 | 0.00 |
| December 31, 2021 | 0.4924 |
| June 30, 2021 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2020 | 0.795 |
| June 30, 2020 | 0.7662 |
| December 31, 2019 | 1.073 |
| June 30, 2019 | 1.411 |
| December 31, 2018 | 1.730 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2021
1.411
Maximum
Jun 2019
0.5545
Average
0.5057
Median
Debt to Equity Ratio Benchmarks
| AC Immune SA | 0.00 |
| CRISPR Therapeutics AG | 0.00 |
| Addex Therapeutics Ltd | 0.00 |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 769.22M |
| Total Liabilities (Quarterly) | 404.39M |
| Shareholders Equity (Quarterly) | 364.82M |
| Current Ratio | 2.332 |
| Net Debt Paydown Yield | -3.55% |